中国工程院2019年院士增选结果,医药卫生学部10人

2019-11-22 二局增选与院士工作处 二局增选与院士工作处

   2019年,中国工程院开展了第14次院士增选和第13次外籍院士增选,共选举产生75位院士和29位外籍院士。    现予公布。中国工程院2019年11月22日中国工程院2019年当选院士名单(按学部顺序排列,同一学部按院士姓名拼音字母顺序排列)机械与运载工程学部(10人)信息与电子工程学部(9人)化工、冶金与材料工程学部(9人)能源与矿业工程学部(9人)土木、水利与建筑工程学部(8人)环境与轻

按:与两周前透露的结果一致:快讯:2019年中国工程院院士,医药卫生学部10人

2019年,中国工程院开展了第14次院士增选和第13次外籍院士增选,共选举产生75位院士和29位外籍院士。

现予公布。

中国工程院

2019年11月22日

中国工程院2019年当选院士名单

(按学部顺序排列,同一学部按院士姓名拼音字母顺序排列)


医药卫生学部(10人)

机械与运载工程学部(10人)

信息与电子工程学部(9人)

化工、冶金与材料工程学部(9人)

能源与矿业工程学部(9人)

土木、水利与建筑工程学部(8人)

环境与轻纺工程学部(7人)

农业学部(7人)


工程管理学部(6人)

中国工程院2019年当选外籍院士名单

(共29人)


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
    2019-11-24 cathymary
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
    2019-11-22 lovetcm

    与二周前结果一样

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1650235, encodeId=2cbf165023506, content=<a href='/topic/show?id=48b935294ef' target=_blank style='color:#2F92EE;'>#医药卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35294, encryptionId=48b935294ef, topicName=医药卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74cd23990687, createdName=circumcision, createdTime=Wed Feb 26 11:46:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2018228, encodeId=7bba2018228b5, content=<a href='/topic/show?id=7cde9833565' target=_blank style='color:#2F92EE;'>#院士增选#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98335, encryptionId=7cde9833565, topicName=院士增选)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6bcd409, createdName=xfpan12, createdTime=Fri Apr 24 01:46:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688168, encodeId=a112168816869, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Sun Apr 19 22:46:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409945, encodeId=a94a14099450e, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500861, encodeId=680415008618b, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Sun Nov 24 06:46:00 CST 2019, time=2019-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=375674, encodeId=2ba83e56745c, content=与二周前结果一样, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Fri Nov 22 21:14:20 CST 2019, time=2019-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049155, encodeId=e0131049155d0, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Fri Nov 22 18:46:00 CST 2019, time=2019-11-22, status=1, ipAttribution=)]
    2019-11-22 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

相关资讯

FDA创新记录,2019年批准了1171个仿制药

美国食品药品监督管理局(FDA)在一份声明中透露,它在2019财年(FY)批准了1171个仿制药,打破了其在2018财年的971个仿制药的纪录。

重磅更新:2019年ADA糖尿病诊疗标准(中文版·中)

美国糖尿病协会制定(海南医学院第一附属医院内分泌科 王新军 王转锁译)

国家卫健委公布2019年医疗美容领域违法违规典型案件

中国国家卫生健康委员会11月11日发布了2019年医疗美容领域部分违法违规典型案件。其发布的典型案件包括:上海郑逸冰医疗美容诊所出借《医疗机构执业许可证》案;王某非医师行医案、上海锦赋医疗美容门诊部有限公司未取得《医疗机构执业许可证》擅自行医案;浙江台州天台美憬医疗美容门诊部有限公司使用非卫生技术人员从事医疗卫生技术工作案;安徽淮南金维医疗美容门诊部诊疗活动超出登记范围案;陕西延安康佼医疗美容门诊

2019年十大突破技术出炉:比尔·盖茨作序,癌症疫苗上榜

当地时间2月27日,《麻省理工科技评论》正式揭晓2019年“十大突破性技术”(10 Breakthrough Technologies),与往年不同的是,今年《麻省理工科技评论》邀请比尔·盖茨作为客座评选人参与评选,并为榜单作序。作为全球新兴科技领域的权威榜单,《麻省理工科技评论》“十大突破性技术”榜已有18年历史。今年上榜的“十大突破性技术”分别是:灵巧机器人、核能新浪潮、早产预测、肠道探测

缅怀!2019年过半 22位中国医学专家离开了我们

2019年已过半,当我们迎来下半年时,这些医者却再也不会变老。据健康界不完全统计,2019年上半年,共有22名中国医学专家离开我们。他们有的倒在工作岗位上,有的在耄耋之年驾鹤西去,有的去世后捐献器官让他人重生……他们无一例外,都将一生都奉献给了热爱的医学事业。7月,回首告别这些离去的医者,让我们回顾他们所做的贡献,并深深地缅怀他们。顾方舟生卒年:1926年6月16日—2019年1月2日 享年9

卫健委谈2019年工作:将推动中医药振兴发展

中新网1月10日电 10日下午,卫健委举行例行新闻发布会,新闻发言人胡强强就2019年卫生健康重点工作进行了简要介绍,提到推进健康中国建设、推动中医药振兴发展等十方面内容。胡强强称,2019年卫生健康重点工作共有十个方面内容。一、推进健康中国建设实施健康中国战略是一项复杂的系统工程,必须调动各方力量。我们将聚焦重要健康影响因素、重点人群和重点疾病,实施一批健康行动。以建设健康城市、健康乡村以及健康